S
Srinivas Ganta
Researcher at Northeastern University
Publications - 36
Citations - 4063
Srinivas Ganta is an academic researcher from Northeastern University. The author has contributed to research in topics: Drug delivery & Cancer. The author has an hindex of 20, co-authored 36 publications receiving 3701 citations. Previous affiliations of Srinivas Ganta include College of Health Sciences, Bahrain & University of Auckland.
Papers
More filters
Journal ArticleDOI
A review of stimuli-responsive nanocarriers for drug and gene delivery
TL;DR: There is a highly promising role of stimuli-responsive nanocarrier systems for drug and gene delivery in the future with greater understanding of the difference between normal and pathological tissues and cells.
Journal ArticleDOI
Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.
Srinivas Ganta,Mansoor M. Amiji +1 more
TL;DR: Combination PTX and CUR therapy was very effective in enhancing the cytotoxicity in wild-type and resistant cells by promoting the apoptotic response, and has significant promise in the clinical management of refractory diseases, especially in ovarian cancer.
Journal ArticleDOI
Role of integrated cancer nanomedicine in overcoming drug resistance
TL;DR: This review presents some of the important principles involved in development of MDR and novel methods of treating cancers using multifunctional-targeted nanoparticles.
Journal ArticleDOI
Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields
Michael Chorny,Ilia Fishbein,Benjamin B. Yellen,Ivan S. Alferiev,Marina Bakay,Srinivas Ganta,Richard F. Adamo,Mansoor M. Amiji,Gary Friedman,Robert J. Levy +9 more
TL;DR: This study demonstrates the feasibility of site-specific drug delivery to implanted magnetizable stents by uniform field-controlled targeting of MNPs with efficacy for in-stent restenosis.
Journal ArticleDOI
Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy.
TL;DR: This review focuses on the current state of nanoemulsions in the translational research and its role in targeted cancer therapy and the production, physico-chemical characterization, and regulatory aspects of nano emulsions are addressed.